Advances in Hematological Malignancies
Recent years have witnessed remarkable progress in the domain of hematological malignancies. Novel therapies such as targeted agents, immunotherapies, and therapy are transforming the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative techniques, offering promise for more successful treatment